RECRUITING

Transcranial Direct Current Stimulation and Chronic Pain

Talk to us

Conditions

Chronic Paintranscranial direct current stimulation

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial uses transcranial direct current stimulation (tDCS) using the patented tKIWI system to safely reduce self-reported chronic pain with little to no side effects to improve our understanding and ability to accurately diagnose pain disorders which would facilitate the development of pharmacologic and non-pharmacologic treatment modalities using deep learning architecture built into the tKIWI.

Official Title

Toward Personalized Treatment of Chronic Pain Using Transcranial Direct Current Stimulation Paired With Deep Learning

Quick Facts

Study Start:2023-06-01
Study Completion:2023-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05863494

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 79 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age: 18-79 years old
  2. * Gender: Any
  3. * Ethnicity: Any
  4. * Chronic pain (\> 3-months); No current use of nonprescription opioids (\< 1 month); Able and willing to comply with scheduled visits and other study-related procedures to complete the study; Willing and able to give informed consent.
  1. * Diagnosis (as defined by DSM-IV) of: any psychotic disorder (lifetime); eating disorder (current or within the past year); obsessive compulsive disorder (lifetime)); mental retardation.
  2. * History of drug or alcohol abuse or dependence (as per DSM-IV criteria) within the last 3 months (except nicotine and caffeine).
  3. * Subject is on regular benzodiazepine medication which it is not clinically appropriate to discontinue.
  4. * Subject requires a rapid clinical response due to inanition, psychosis or high suicide risk.
  5. * Neurological disorder or insult, e.g., recent stroke (CVA), which places subject at risk of seizure or neuronal damage with tDCS.
  6. * Subject has metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
  7. * Female subject who is pregnant.
  8. * Participants who are not fluent in English will not be included in the trial for safety reasons: a) It is usually not possible to have an interpreter reliably available every weekday for up to 4 weeks and it is not safe to give tDCS to a subject who cannot tell us immediately of any side effects; Note that translation of the proposed ACT activity into English has not been validated and that we cannot be confident that they would be accurately translated and validated.
  9. * Minors
  10. * Older than 79 years old
  11. * last use \>24 months
  12. * history of EEG or any electrical implant (i.e. pacemaker)
  13. * history of Parkinson's, diagnosis of bipolar, schizophrenia/schizo-affective d/o, OCD, epilepsy, alzheimers
  14. * taking antipsychotic drugs

Contacts and Locations

Study Contact

Allison J Huff, DHEd
CONTACT
(520) 626-4839
allison7@arizona.edu
Leena Idris, BS
CONTACT
(520) 2474415
idris1@arizona.edu

Principal Investigator

Allison J Huff, DHEd
PRINCIPAL_INVESTIGATOR
University of Arizona

Study Locations (Sites)

University of Arizona
Tucson, Arizona, 85719
United States

Collaborators and Investigators

Sponsor: University of Arizona

  • Allison J Huff, DHEd, PRINCIPAL_INVESTIGATOR, University of Arizona

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-01
Study Completion Date2023-10

Study Record Updates

Study Start Date2023-06-01
Study Completion Date2023-10

Terms related to this study

Keywords Provided by Researchers

  • chronic pain
  • transcranial direct current stimulation

Additional Relevant MeSH Terms

  • Chronic Pain